LmjMAPK10 offers protection against Leishmania donovani infection.
This study aimed at evaluating the DNA vaccination efficacy of Leishmania major-derived MAPK10 against Leishmania donovani infection. MAPK10 is one of 15 mitogen-activated protein kinases (MAPKs) of Leishmania major. Herein, we expressed the gene through a mammalian vector and tested whether priming with this gene would offer protection against L. donovani infection. We report that LmjMAPK10 DNA vaccination using a mammalian expression vector significantly reduces the parasite burden. The protection is accompanied by host-protective T cell functions, TH 1-type cytokines and elevated leishmanial antigen-specific IgG2a isotype response. T cell response to the L. donovani / challenge infection is associated with increase in IL-12 and IFN-γ, but reduced IL-10 and IL-4 production. LmjMAPK10 is cross-protective against L. donovani infection.